Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.60 |
| ▸ | LPL | P06858 | 9/20 | 0.60 |
| ▸ | BACE1 | P56817 | 2/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | P4HB | P07237 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | PELI1 | Q96FA3 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29871636 | 1.00 | LIPG (0.60) | LIPGLPLBACE1PDGFRBKDR | |
| SCHEMBL23303470 | 0.89 | LIPG (0.62) | LIPGLPLBACE1PDGFRBKDR | |
| SCHEMBL29871639 | 0.89 | LIPG (0.62) | LIPGLPLBACE1PDGFRBKDR | |
| SCHEMBL29653625 | 0.85 | LIPG (0.66) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL19533269 | 0.85 | LIPG (0.66) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL16788914 | 0.83 | LIPG (0.62) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL26546881 | 0.83 | LIPG (0.62) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL28470742 | 0.81 | LIPG (0.60) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL27263102 | 0.81 | LIPG (0.60) | LIPGLPLPDGFRBKDRP4HB | |
| SCHEMBL2265622 | 0.81 | LIPG (0.64) | LIPGLPLPDGFRBKDRP4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12471490-B2 | Organic compound, organic light-emitting diode including organic compound, and display device including organic light-emitting diode | SOULBRAIN CO., LTD (KR) | 2025-11-11 | — | — | US | disclosed |
| US-20220407012-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE | SOULBRAIN CO., LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| US-20220407012-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE | SOULBRAIN CO., LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| EP-4053119-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE | Soulbrain Co., Ltd. (KR) | 2022-09-07 | — | — | EP | disclosed |
| US-11374177-B2 | Compound and organic light emitting device comprising the same | SOULBRAIN CO., LTD. (KR) | 2022-06-28 | — | — | US | disclosed |
| WO-2021086143-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND DISPLAY DEVICE COMPRISING ORGANIC LIGHT-EMITTING DIODE | 솔브레인 주식회사 | 2021-05-06 | — | — | WO | disclosed |
| WO-2020153542-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | 솔브레인 주식회사 | 2020-07-30 | — | — | WO | disclosed |
| US-20200235309-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
| US-20120053345-A1 | Indazole Compounds | ABBOTT LABORATORIES (US) | 2012-03-01 | — | — | US | disclosed |
| US-8008481-B2 | Indazole compounds | ABBVIE INC. | 2011-08-30 | — | — | US | disclosed |
| US-20070282101-A1 | Indazole compounds | ABBVIE INC. | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282101-A1 | Indazole compounds | CYP3A43, CYP3A7, UGT1A1 | LIPG 3363/4885LPL 3658/4885BACE1 687/4885 |
| US-11374177-B2 | Compound and organic light emitting device comprising the same | CRY1, CRY2, AOX1 | LIPG 1635/4885LPL 608/4885BACE1 230/4885 |
| US-20220407012-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING ORGANIC COMPOUND, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT-EMITTING DIODE | OCIAD1, AOX1, OXER1 | LIPG 2144/4885LPL 416/4885BACE1 305/4885 |
| US-20200235309-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, AOX1 | LIPG 1635/4885LPL 608/4885BACE1 230/4885 |
| US-20120053345-A1 | Indazole Compounds | CYP3A43, CYP3A7, UGT1A1 | LIPG 3363/4885LPL 3658/4885BACE1 687/4885 |
| US-12471490-B2 | Organic compound, organic light-emitting diode including organic compound, and display device including organic light-emitting diode | OCIAD1, AOX1, OXER1 | LIPG 2144/4885LPL 416/4885BACE1 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.